[1] [1] CHEN Weiwei, GAO Runlin, LIU Lisheng, et al. Outline of 2017 China cardiovascular disease report［J］. Chinese Circulation Journal, 2018, 3(1): 1-8.

[2] [2] DASH D. Percutaneous coronary rotational atherectomy:does it make sense in 2018［J］. Journal of Indian College of Cardiology, 2018, 8(2), 80-86.

[3] [3] LU Changlin, GUO Weihua, YANG Yuejin, et al. In-stent coronary restenosis, status and prospects［J］. Chinese Journal of Cardiovascular Medicine, 2012, 17(6): 409-412.

[4] [4] ZHANG M, ZHENG W P, YANG M, et al. Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease［J］. Clinica Chimica Acta, 2017, 471(8): 150-153.

[5] [5] CHEN Kaiming. Research focus analysis of coronary restenosis based on PubMed database［J］. China Modern Medicine, 2017, 24(31): 29-32.

[6] [6] ZHEN Junchen, MA Xiaoyuan, GAO Bo, et al. Influencing factors of restenosis after percutaneous coronary intervention［J］. Practical Journal of Cerebral Pneumal and Vascular Disease, 2016, 24(2): 16-19.

[7] [7] LUDMAN P F, Percutaneous coronary intervention［J］. Medicine, 2018, 46(9): 547-554.

[8] [8] XIAO Chongchong, HUANG Xiansheng. Factors influencing the diagnostic accuracy of coronary heart disease by multi-slice spiral CT［J］. Chinese Journal of Gerontology, 2018, 38(14): 3575-3577.

[9] [9] LIU Guoyong. Advantages and disadvantages of non-invasive imaging diagnosis of coronary heart disease and its research progress［J］. Medical Information, 2014, 27(9): 587.

[10] [10] XIAO Ruoxiu. Study on structure identification and matching of coronary arteries in X-ray angiograms［D］. Beijing Institute of Technology, 2014.

[11] [11] LI Qiang. Cerebral angiography DSA surgery complications clinical analysis［J］. Modern Medical Imagelogy, 2015, 24(4): 685-686.

[12] [12] HAO Shourong. Experience of emergency nursing of allergy of contrast agent during PCI［J］. Chinese Remedies & Clinics, 2015, 15(2): 289-290.

[13] [13] RAO Zhiqing, SUN Chunyan. Treatment and analysis of five cases of iodine allergy［J］. Chinese General Practice, 2007, 10(18): 1539-1539.

[14] [14] Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients［J］. British Medical Journal, 2002, 324(7329): 71-86.

[15] [15] BAIGENT C, BLACKWELL L, COLLINS R, et al. Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomized trials［J］. Lancet, 2009, 373(9678): 1849-1860.

[16] [16] CUI Linlin, GAO Guojie, HU Taohong. The efficacy of aspirin in the treatment of primary hypertension with CHD and its effect on plasma viscosity and platelet aggregation rate［J］. Hebei Medicine, 2018, 24(2): 211-215.

[17] [17] TANG Haiqin, YANG Linlin, HU Shilian, et al. Effects of low-dose aspirin on primary prevention of cardiovascular events:a systematic review［J］. Chinese Journal of Cardiology, 2010, 38(4): 315-320.

[18] [18] SHEN Deliang, LIU Chuang. Study on the correlation between the changes of coronary artery scores in coronary heart disease patients and their statins compliance and blood lipid control rate［J］. Medicine & Philosophy, 2018, 39(5): 38-39, 43.

[19] [19] ZHAO Jia, LI Gang. Indications for statins in primary prevention of cardiovascular disease［J］. Clinical Focus, 2018, 33(6): 465-468.

[20] [20] FU Menglu, DONG Ruolan, TU Ling, et al. Reserach progress in clopidogrel resistance［J］. Herald of Medicine, 2018, 37(2): 139-145.

[21] [21] SOLOMON M D, GO A S, SHILANE D, et al. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction［J］. Journal of the American College of Cardiology, 2014, 63(21): 2249-2257.

[22] [22] CHEN Q, YANG Y, LIU Y, et al. Safety and effectiveness of percutaneous coronary intervention in elderly patients. A 5-year consecutive study of 201 cases with PCI［J］. Archives of Gerontology and Geriatrics, 2010, 51(3): 312-316.

[23] [23] WODLINGER A M, PIEPERR J A. The role of clopidogrel in the management of acute coronary syndromes［J］. Clinical Therapeutics, 2003, 25(8): 2155-2181.

[24] [24] ZHENG Bin, DONG Jinchao, SU Lizhong,et al. Surface-enhanced Raman spectroscopy study of fresh human urine:a preliminary study［J］. Spectroscopy and Spectral Analysis, 2016, 36(6): 1987-1991.

[25] [25] ZHAO Chang, LI Rong, YANG Huinan, et al. Measurement of platelet-derived growth factor-BB in urine samples based on surface-enhanced Raman spectroscopy［J］. Chinese Journal of Lasers, 2017, 44(8): 288-294.

[26] [26] YANG H N, ZHAO C, LI R, et al. Noninvasive and prospective diagnosis of coronary heart disease with urine using surface-enhanced Raman spectroscopy.［J］. Analyst, 2018, 143(10): 2235-2242.

[27] [27] LI Rong, SHEN Chengxing, WU Meiqing, et al. Clinical study of the correlation between the concentration of platelet-derived growth factor-BB and the risk of coronary stent restenosis［J］. Modern Medical Journal, 2017, 45(6): 766-770.